Today: 15 March 2026
Intel stock slips as Trump bump cools and analysts stay cautious ahead of earnings
12 January 2026
1 min read

Intel stock slips as Trump bump cools and analysts stay cautious ahead of earnings

NEW YORK, Jan 12, 2026, 10:38 AM EST — Regular session

  • Intel shares dropped roughly 1% as traders took profits following last week’s rally.
  • Susquehanna raised its price target but kept a Neutral rating, flagging concerns about PC and data-center demand.
  • Investors are shifting focus to Intel’s Jan. 22 earnings, looking for clues on demand and how well manufacturing is holding up.

Intel shares dropped 1.1% to $45.06 in early Monday trading, retreating slightly after a strong rally that thrust the chipmaker back into the spotlight on momentum screens.

This pullback is significant because Intel’s recent rally has been driven more by sentiment—Washington politics, product news, and hopes of regaining ground in PCs and manufacturing—than by solid data.

As earnings approach, traders are zeroing in on tougher questions: Is PC demand staying steady? Are data-center sales leveling off? And can Intel’s foundry effort — its contract chipmaking division — shift from lofty goals to consistent revenue?

Susquehanna analyst Christopher Rolland bumped his price target to $40 from $35 on Monday but stuck with a Neutral rating, citing ongoing challenges in PCs and data centers. “We view this multiple as appropriate given PC and DC headwinds, historical valuation metrics, and large-cap peer valuations,” Rolland said, referring to the enterprise value-to-sales ratio. Barron’s

Intel surged 10.8% in the previous session, powering a wider rally across chipmakers amid a risk-on push. The jump came after U.S. President Donald Trump posted about a meeting with Intel CEO Lip-Bu Tan. Reuters

Trump posted on Truth Social about a “great meeting” with Tan, adding that the U.S. government is “proud” to be an Intel shareholder after acquiring about a 10% stake last year, according to Investopedia’s summary of the post. Investopedia

Intel’s pitch around new “AI PC” chips has fueled hopes of reviving a slow laptop upgrade cycle. Yet at CES in Las Vegas, doubts persisted about whether buyers will actually shell out for the concept. “I think the general consumer is still not aware of what an AI PC really means or what it can do for them that they can’t do today,” said Ben Bajarin, CEO of Creative Strategies and a tech consultant, in an interview with Reuters. Reuters

Chip stocks showed mixed results Monday. Advanced Micro Devices climbed nearly 2.6%, Broadcom added around 1%, and Nvidia held steady.

The risk hasn’t disappeared. Intel is working to regain trust in PCs and data centers, pouring money into manufacturing expansion. Yet investors remain cautious, seeking firmer proof that external customers will actually fill those factories on a significant scale.

Intel will release its fourth-quarter and full-year 2025 results on Jan. 22, after the market close, the company announced this month. The earnings call is set for 2 p.m. Pacific time that day. Intel Corporation

Stock Market Today

  • Live Cattle Futures Close Mixed Amid Falling Wholesale Beef Prices and Lower Slaughter Numbers
    March 15, 2026, 4:31 AM EDT. Live cattle futures ended Friday steady to slightly higher, with February contracts down $3.825 for the week. Cash prices fell $2-$4 across northern and southern US markets. Feeder cattle futures declined 10 to 40 cents Friday, closing the week sharply lower, pressured by a $10.825 weekly drop in March contracts. The CME Feeder Cattle Index slipped further to 275.59 on February 6. Speculators reduced net long positions significantly in both live and feeder cattle futures, per Commitment of Traders data. USDA wholesale boxed beef prices dropped, with Choice boxes down $2.11 at $321.87/cwt. Federally inspected cattle slaughter was estimated at 584,000 head, down 16,000 from last week and over 33,000 from last year, influencing market dynamics.
Moderna stock slides as $1.9 billion sales view fails to calm investors (MRNA)
Previous Story

Moderna stock slides as $1.9 billion sales view fails to calm investors (MRNA)

Jaguar Health stock swings as Future Pak licensing deal dangles $38 million — here’s what traders see
Next Story

Jaguar Health stock swings as Future Pak licensing deal dangles $38 million — here’s what traders see

Go toTop